These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 32383806)

  • 41. Prenatal and perinatal factors and cerebral palsy in very low birth weight infants.
    Grether JK; Nelson KB; Emery ES; Cummins SK
    J Pediatr; 1996 Mar; 128(3):407-14. PubMed ID: 8774515
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association of placental weight with cerebral palsy: population-based cohort study in Norway.
    Strand KM; Andersen GL; Haavaldsen C; Vik T; Eskild A
    BJOG; 2016 Dec; 123(13):2131-2138. PubMed ID: 26692053
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Losing a diagnosis of cerebral palsy: a comparison of variables at 2 and 5 years.
    Chen A; Dyck Holzinger S; Oskoui M; Shevell M;
    Dev Med Child Neurol; 2020 Jan; 62(1):83-88. PubMed ID: 31273776
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epidemiology of cerebral palsy in Bangladesh: a population-based surveillance study.
    Khandaker G; Muhit M; Karim T; Smithers-Sheedy H; Novak I; Jones C; Badawi N
    Dev Med Child Neurol; 2019 May; 61(5):601-609. PubMed ID: 30394528
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antenatal magnesium sulfate and neuroprotection.
    Doyle LW
    Curr Opin Pediatr; 2012 Apr; 24(2):154-9. PubMed ID: 22227787
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predictors for early diagnosis of cerebral palsy from national registry data.
    Granild-Jensen JB; Rackauskaite G; Flachs EM; Uldall P
    Dev Med Child Neurol; 2015 Oct; 57(10):931-5. PubMed ID: 25855100
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Completeness and correctness of cerebral palsy diagnoses in two health registers: implications for estimating prevalence.
    Hollung SJ; Vik T; Wiik R; Bakken IJ; Andersen GL
    Dev Med Child Neurol; 2017 Apr; 59(4):402-406. PubMed ID: 27896812
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Prevention of cerebral palsy using magnesium sulfate in pre-term newborns].
    Marret S; Chollat C; Levèque C; Marpeau L
    Arch Pediatr; 2011 Mar; 18(3):324-30. PubMed ID: 21257296
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Magnesium sulphate for the prevention of cerebral palsy in Australia and New Zealand.
    Bain E; Goodchild L; Lontis R; McIntyre S; Ashwood P; Bubner T; Middleton P; Crowther C
    Aust Nurs J; 2013 Jul; 21(1):34-7. PubMed ID: 23930314
    [No Abstract]   [Full Text] [Related]  

  • 50. Preterm premature rupture of membranes at 22-25 weeks' gestation: perinatal and 2-year outcomes within a national population-based study (EPIPAGE-2).
    Lorthe E; Torchin H; Delorme P; Ancel PY; Marchand-Martin L; Foix-L'Hélias L; Benhammou V; Gire C; d'Ercole C; Winer N; Sentilhes L; Subtil D; Goffinet F; Kayem G
    Am J Obstet Gynecol; 2018 Sep; 219(3):298.e1-298.e14. PubMed ID: 29852153
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of visual support strategies on the quality of life of children with cerebral palsy and cerebral visual impairment/perceptual visual dysfunction in Nigeria: study protocol for a randomized controlled trial.
    Duke R; Eyong K; Burton K; MacLeod D; Dutton GN; Gilbert C; Bowman R
    Trials; 2019 Jul; 20(1):417. PubMed ID: 31291989
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Magnesium sulfate for the prevention of cerebral palsy.
    Rouse DJ
    Am J Obstet Gynecol; 2009 Jun; 200(6):610-2. PubMed ID: 19482114
    [TBL] [Abstract][Full Text] [Related]  

  • 53. SOGC Clinical Practice Guideline. Magnesium sulphate for fetal neuroprotection.
    Magee L; Sawchuck D; Synnes A; von Dadelszen P; ;
    J Obstet Gynaecol Can; 2011 May; 33(5):516-529. PubMed ID: 21639972
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cerebral Palsy in Extremely Preterm Infants.
    Hafström M; Källén K; Serenius F; Maršál K; Rehn E; Drake H; Ådén U; Farooqi A; Thorngren-Jerneck K; Strömberg B
    Pediatrics; 2018 Jan; 141(1):. PubMed ID: 29222398
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cerebral palsy in very low birth weight infants, pre-eclampsia and magnesium sulphate.
    Blair E; Palmer L; Stanley F
    Pediatrics; 1996 May; 97(5):780-2. PubMed ID: 8628635
    [No Abstract]   [Full Text] [Related]  

  • 56. Is cerebral palsy associated with birth defects other than cerebral defects?
    Blair E; Al Asedy F; Badawi N; Bower C
    Dev Med Child Neurol; 2007 Apr; 49(4):252-8. PubMed ID: 17376134
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Magnesium sulfate in labor and risk of neonatal brain lesions and cerebral palsy in low birth weight infants. The Neonatal Brain Hemorrhage Study Analysis Group.
    Paneth N; Jetton J; Pinto-Martin J; Susser M
    Pediatrics; 1997 May; 99(5):E1. PubMed ID: 9113958
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prenatal stress and cerebral palsy: a nationwide cohort study in Denmark.
    Li J; Vestergaard M; Obel C; Precht DH; Christensen J; Lu M; Olsen J
    Psychosom Med; 2009 Jul; 71(6):615-8. PubMed ID: 19483121
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hospital admissions in children with cerebral palsy: a data linkage study.
    Meehan E; Reid SM; Williams K; Freed GL; Sewell JR; Vidmar S; Donath S; Reddihough DS
    Dev Med Child Neurol; 2017 May; 59(5):512-519. PubMed ID: 27900776
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Magnesium sulfate, chorioamnionitis, and neurodevelopment after preterm birth.
    Kamyar M; Manuck TA; Stoddard GJ; Varner MW; Clark E
    BJOG; 2016 Jun; 123(7):1161-6. PubMed ID: 26036660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.